Codes / ICD10CM / C75.3

C75.3 Malignant neoplasm of pineal gland

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Malignant neoplasm of pineal gland
  • ICD-10 Code: C75.3

Summary

Malignant neoplasm of the pineal gland refers to cancerous growths originating in the pineal gland, a small endocrine gland located in the brain. This gland produces melatonin, which regulates sleep-wake cycles. Malignancies can disrupt hormonal balance and may cause neurological symptoms due to the gland's proximity to critical brain structures.

Causes

The development of this malignancy involves genetic mutations that cause uncontrolled cell growth in pineal tissue. Contributing factors may include inherited genetic syndromes, sporadic mutations, or environmental exposures. The exact triggers are not fully understood.

Risk Factors

  • Genetic syndromes (e.g., germline mutations)
  • Prior radiation exposure to the brain
  • Family history of central nervous system or endocrine cancers
  • Age (risk increases with age)
  • History of benign pineal conditions

Symptoms

  • Headaches or increased intracranial pressure
  • Visual disturbances (e.g., double vision, blurred vision)
  • Hormonal imbalances (e.g., sleep pattern changes)
  • Nausea, vomiting, or dizziness
  • Neurological deficits (e.g., weakness, coordination issues)

Diagnosis

Diagnosis typically involves imaging studies such as MRI or CT scans to identify abnormal growth in the pineal region. Blood tests may assess hormonal levels, and a biopsy may confirm malignancy. Additional evaluations may include neurological examinations to assess function.

Treatment Options

Treatment may include surgical resection, radiation therapy, or chemotherapy, depending on the tumor's size, location, and extent. Targeted therapies or clinical trials may be considered for specific cases. Multidisciplinary care involving neurosurgeons, oncologists, and endocrinologists is often recommended.

Prognosis and Follow-Up

Prognosis varies based on tumor type, stage, and response to treatment. Regular follow-up with imaging and clinical assessments is essential to monitor for recurrence or progression. Long-term management may address hormonal or neurological effects.

Complications

Potential complications include increased intracranial pressure, vision loss, hormonal imbalances, or neurological deficits. Treatment-related side effects (e.g., from radiation or chemotherapy) may also occur.

Lifestyle & Prevention

No specific preventive measures exist, but maintaining overall health and avoiding known risk factors (e.g., unnecessary radiation exposure) may reduce risk. Supportive care, including sleep hygiene and stress management, may help manage symptoms.

When to Seek Professional Help

Seek medical attention for persistent headaches, visual changes, hormonal symptoms, or neurological issues. Prompt evaluation is important if symptoms worsen or new ones develop.

Tips for Medical Coders

Document the specific histological type and laterality (if applicable) when available. Ensure clinical correlation with imaging or biopsy results to confirm the pineal gland as the primary site. Code C75.3 is specific to the pineal gland; avoid using it for other endocrine or brain tumors.

Medical Policies and Guidelines

Related policies from health plans

Book a walkthrough

C75.3 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.